Purchase Order 75N95023P00696

Award Date 9/1/23
Potential Completion Date 8/31/24
Potential Value $1M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $575,000.00 firm fixed price purchase order contract to Brain Biosciences Inc., doing business as Brain Bio, for a primate positron emission tomography (PET) scanner. The contract does not have a set-aside designation. The PET scanner is intended to support the Institute's Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit's research into the neurobiological...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1.6 million firm fixed price purchase order to Mediso USA LLC. The contract calls for Mediso to deliver one Multiscan LFER 150 PET/CT preclinical imaging system with 1mm resolution to accommodate rhesus macaques. Installation, training, a one-year warranty, and software upgrades are also included. This award fulfills a solicitation request from the NIH Molecular Imaging Branch...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Brain Biosciences Inc. (dba Brain Bio) for extended warranty and technical support services for a BBI-piPET-314-13 PET scanner. The potential value of the contract is $166,909.00 and the period of performance is from April 18, 2022 to April 17, 2023, with a final completion date of April 17, 2025. The contract was not set aside for...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), awarded a $168,000.00 firm fixed price purchase order contract to Mediso USA, LLC for a 12-month preventative maintenance and service package for a Mediso NanoScan Positron Emission Tomography/Computed Tomography (PET/CT) animal imager. The contract has a base period from February 11, 2025 to February 10, 2026, with four 12-month option periods that could extend the contract through February...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $22,349 purchase order to Pmod Technologies LLC, a subsidiary of Bruker Corporation, to provide pet analysis software. The software will support Dr. Bradberry's research analyzing data from positron emission tomography experiments and is considered a firm fixed price contract. Performance will take place in Baltimore, Maryland over the course of one year beginning in September...
The U.S. National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a $68,297.40 firm fixed-price purchase order to Les Recherches Rogue Inc. (Rogue Research Inc. Division), a for-profit manufacturer of specialized equipment for neuroscience research. The contract is for the delivery of a Brainsight Navigator system for non-invasive brain stimulation with computer and electromyography capabilities. This purchase order was...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $113,000.00 firm fixed-price purchase order to Inscopix, Inc., a for-profit organization, for the nVoke 2.0 Integrated Calcium Imaging and Optogenetics System for Rodents. This system will enable the NIH National Institute of Mental Health's (NIMH) Dendritic Dynamics Hub to expand its research on dendritic dynamics, neural circuit dynamics, and neuronal activity in awake,...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $458,593 firm-fixed-price purchase order to Bruker Nano, Inc. for an Ultima 2Pplus Laser Scanner with peripherals. The solicitation sought a multi-photon microscopy system with 3D spatial light modulator photostimulation capabilities to support research at the NIH campus in Bethesda, Maryland. There was no set-aside designation for this requirement under the applicable North...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $24,250.00, is for the delivery of Brainbox LTD's NEUROFUS DEEP TRANSDUCER, a specialized medical device used to modulate neural activity in deeper areas of the human brain. This technology supports NIDA's research efforts, which include the study of addiction and other neurological conditions. The...
This is a firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Brain Research And Development Services LTD, a foreign-owned for-profit organization that manufactures goods. The contract has a ceiling value of $90,000.00 and a period of performance through May 30, 2017. It does not have a set-aside designation. The contract was awarded on September 24, 2015 and is related to the BRAIN (Brain Research through Advancing Innovative...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1,032,950 firm fixed price purchase order to Brain Biosciences Inc., doing business as Brain Bio, to deliver a human/primate hi-resolution upright PET scanner upgrade. The solicitation sought a pPET Ultra-High Resolution Detector Upgrade for an existing scanner, including installation, user training, warranty, and maintenance services. The upgrade is needed to provide pre-clinical images of large primates and humans in an upright, sitting position with high 1.5mm or better resolution and a small physical footprint. Work will be performed in Baltimore, Maryland over a one year period ending August 2024. There is no set-aside designation. This purchase supports NIH/NIDA's ongoing pre-clinical research using PET imaging technology.

Generated 12/29/23, 2:50 PM